King’s Mill receives 1,000th UK installation of trophon device

Installations of Nanosonics’ trophon device in the UK have come full circle, with the 1,000th system going to King’s Mill Hospital, which was the first location to receive a device. Manufactured in Sydney, Australia, the trophon automated system for high level disinfection of ultrasound probes came to the UK in 2013, with the installation at King’s Mill Hospital funded by Sherwood Forest Hospitals NHS Foundation Trust.

In 2021 the UK Nanosonics team hit the milestone of the 1,000th installation of the system.

Lead sonographer Louise Cordon explained why the hospital chose the technology: “We chose trophon primarily due to its ease of use – it provides high level disinfection at the touch of a button.”

Listing the main benefits of installing trophon technology, Cordon mentioned that it was user friendly, easy to install and maintain, and reduced exposure to chemicals and spills due to the system being sealed. She also pointed to the system’s cleanliness and the speed of the disinfection cycle. Built-in fail-safe features include a chemical indicator.

Nanosonics points out that, since 2013, there have been updates to guidance on the reprocessing of ultrasound probes in Wales, Scotland and Northern Ireland. It is recommended that high level disinfection and automation should be used when reprocessing semi-critical ultrasound probes. In England, The Society of Radiographers and British Medical Ultrasound Society have stated that automation is the preferred best practice for the decontamination of ultrasound probes.

Read the full installation case study here.

Picture: King’s Mill Hospital sonographers Neelam Shabir and Maria Ball, Nanosonics UK marketing manager Felicity Jones and UK country manager Bryn Tudor-Owen, lead sonographer Louise Cordon, sonographer Steven Ashton and radiography services manager Sarah Sentence.

Published on the front page of the January 2022 issue of RAD Magazine.

You might also like

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more